ウェアラブル非侵襲血糖モニタリングデバイスの世界市場成長2023-2029年Global Wearable Non-invasive Blood Glucose Monitoring Device Market Growth 2023-2029 弊社(LP Info Research)の最新調査によると、ウェアラブル非侵襲血糖モニタリングデバイスの世界市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加とCOVID-19やロシア・ウクライナ戦争の... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー弊社(LP Info Research)の最新調査によると、ウェアラブル非侵襲血糖モニタリングデバイスの世界市場規模は2022年に100万米ドルと評価されました。川下市場での需要の増加とCOVID-19やロシア・ウクライナ戦争の影響からの回復により、ウェアラブル非侵襲血糖モニタリングデバイスは、レビュー期間中のCAGR %で2029年までに百万米ドルの再調整された規模になると予測されています。この調査レポートは、世界のウェアラブル非侵襲血糖モニタリングデバイス市場の成長可能性を明らかにしています。COVID-19やロシア・ウクライナ戦争の影響からの回復に伴い、ウェアラブル非侵襲血糖モニタリングデバイスは今後の市場で安定した成長を示すと予想される。しかし、ウェアラブル非侵襲血糖モニタリングデバイスの普及には、製品の差別化、コスト削減、サプライチェーンの最適化が引き続き重要である。市場プレイヤーは、ウェアラブル非侵襲血糖モニタリングデバイス市場が提供する膨大な機会を活用するために、研究開発に投資し、戦略的パートナーシップを構築し、進化する消費者の嗜好に合わせた製品を提供する必要があります。 ウェアラブル非侵襲性血糖モニタリング・デバイスは、皮膚を刺して血液サンプルを採取するような侵襲的な処置を必要とせずに、個人の血糖値を測定するように設計されたウェアラブル技術の一種である。この種の装置は通常、光学センサー、電磁センサー、熱センサーなどの非侵襲的技術を使用して、血糖値をリアルタイムで測定する。この装置は通常、手首など身体に装着して使用し、血糖値の継続的な監視が可能であるため、糖尿病患者など、病状を管理するために定期的に血糖値を監視する必要がある場合に特に有用である。 主な特徴 ウェアラブル非侵襲血糖モニタリングデバイス市場に関するレポートは、様々な側面を反映し、業界に関する貴重な洞察を提供します。 市場規模と成長:この調査レポートは、ウェアラブル非侵襲血糖モニタリングデバイス市場の現在の規模と成長の概要を提供します。過去データ、タイプ別(連続型、間欠型など)の市場区分、地域別内訳などが含まれる場合があります。 市場促進要因と課題:当レポートでは、政府規制、環境問題、技術進歩、消費者嗜好の変化など、ウェアラブル非侵襲血糖測定器市場の成長を促進する要因を特定・分析することができます。また、インフラの制限、航続距離への不安、初期コストの高さなど、業界が直面する課題も浮き彫りにすることができます。 競合情勢:この調査レポートは、ウェアラブル非侵襲型血糖モニタリングデバイス市場内の競合状況の分析を提供しています。主要企業のプロフィール、市場シェア、戦略、製品提供などが含まれる。また、新興企業や市場に与える潜在的な影響にもスポットを当てています。 技術開発:この調査レポートは、ウェアラブル非侵襲血糖モニタリングデバイス産業における最新の技術開発を掘り下げることができます。これには、ウェアラブル非侵襲性血糖モニタリングデバイス技術の進歩、ウェアラブル非侵襲性血糖モニタリングデバイスの新規参入企業、ウェアラブル非侵襲性血糖モニタリングデバイスの新規投資、ウェアラブル非侵襲性血糖モニタリングデバイスの将来を形作るその他の技術革新などが含まれます。 川下の事業者の好み:このレポートは、ウェアラブル非侵襲性血糖モニタリングデバイス市場における顧客の購買行動と採用動向を明らかにすることができます。このレポートには、顧客の購買決定、ウェアラブル非侵襲血糖モニタリングデバイス製品の嗜好に影響を与える要因が含まれています。 政府の政策とインセンティブこの調査レポートは、ウェアラブル非侵襲血糖モニタリングデバイス市場に対する政府の政策とインセンティブの影響を分析しています。これには、規制の枠組み、補助金、税制優遇措置、ウェアラブル非侵襲血糖モニタリングデバイス市場の促進を目的としたその他の措置の評価が含まれます。また、市場成長促進におけるこれらの政策の有効性も評価します。 環境への影響と持続可能性当調査レポートでは、ウェアラブル非侵襲血糖モニタリングデバイス市場の環境への影響と持続可能性の側面を評価しています。 市場予測と将来展望:当調査レポートでは、実施した分析に基づいて、ウェアラブル非侵襲血糖モニタリングデバイス産業の市場予測と展望を提供しています。これには、市場規模、成長率、地域動向、技術進歩や政策展開に関する予測などが含まれます。 提言と機会:本レポートは、業界関係者、政策立案者、投資家への提言で締めくくられています。市場関係者が新たなトレンドを活用し、課題を克服し、ウェアラブル非侵襲血糖モニタリングデバイス市場の成長と発展に貢献するための潜在的な機会を強調しています。 市場の細分化 ウェアラブル非侵襲血糖モニタリングデバイス市場は、タイプ別と用途別に分けられる。2018-2029年の期間について、セグメント間の成長は、タイプ別、アプリケーション別の消費額について、数量と金額で正確な計算と予測を提供します。 タイプ別セグメント 連続的 断続的 用途別セグメント スポーツ&エンターテインメント 医療 医療研究 その他 本レポートでは、市場を地域別にも分割しています: 南北アメリカ アメリカ カナダ メキシコ ブラジル APAC 中国 日本 韓国 東南アジア インド オーストラリア ヨーロッパ ドイツ フランス 英国 イタリア ロシア 中東・アフリカ エジプト 南アフリカ イスラエル トルコ GCC諸国 以下の企業は、主要な専門家から収集した情報、および企業のカバレッジ、製品ポートフォリオ、市場浸透度の分析に基づいて選択されています。 ノウ・ラボ グラフウェア ADI クォンタム・オペレーション ダイヤモンテック ハガーテック ライフプラス アフォンテクノロジー アボット デックスコム クノーガ・メディカル インテグリティ・アプリケーション 台湾バイオフォトニック メディワイズ グライセンス社 グルコワイズ NXP アップル ファーウェイ 本レポートで扱う主な質問 ウェアラブル非侵襲血糖モニタリングデバイスの世界市場の10年展望は? ウェアラブル非侵襲血糖モニタリングデバイスの世界市場および地域別市場成長を促進する要因は何か? 市場別・地域別で最も急成長するのはどの技術か? ウェアラブル非侵襲血糖モニタリングデバイスの市場機会は最終市場規模によってどのように異なるのか? ウェアラブル非侵襲血糖モニタリングデバイスのタイプ別、用途別内訳は? COVID-19とロシア・ウクライナ戦争の影響は? 目次1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Wearable Non-invasive Blood Glucose Monitoring Device by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Wearable Non-invasive Blood Glucose Monitoring Device by Country/Region, 2018, 2022 & 2029 2.2 Wearable Non-invasive Blood Glucose Monitoring Device Segment by Type 2.2.1 Continuous 2.2.2 Intermittent 2.3 Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type 2.3.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Sales Market Share by Type (2018-2023) 2.3.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue and Market Share by Type (2018-2023) 2.3.3 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Price by Type (2018-2023) 2.4 Wearable Non-invasive Blood Glucose Monitoring Device Segment by Application 2.4.1 Sports & Entertainment 2.4.2 Medical 2.4.3 Medical Research 2.4.4 Others 2.5 Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application 2.5.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Market Share by Application (2018-2023) 2.5.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue and Market Share by Application (2018-2023) 2.5.3 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Price by Application (2018-2023) 3 Global Wearable Non-invasive Blood Glucose Monitoring Device by Company 3.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Breakdown Data by Company 3.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales by Company (2018-2023) 3.1.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Sales Market Share by Company (2018-2023) 3.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue by Company (2018-2023) 3.2.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Company (2018-2023) 3.2.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue Market Share by Company (2018-2023) 3.3 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Price by Company 3.4 Key Manufacturers Wearable Non-invasive Blood Glucose Monitoring Device Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Wearable Non-invasive Blood Glucose Monitoring Device Product Location Distribution 3.4.2 Players Wearable Non-invasive Blood Glucose Monitoring Device Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Wearable Non-invasive Blood Glucose Monitoring Device by Geographic Region 4.1 World Historic Wearable Non-invasive Blood Glucose Monitoring Device Market Size by Geographic Region (2018-2023) 4.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Wearable Non-invasive Blood Glucose Monitoring Device Market Size by Country/Region (2018-2023) 4.2.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales by Country/Region (2018-2023) 4.2.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue by Country/Region (2018-2023) 4.3 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth 4.4 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth 4.5 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth 4.6 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth 5 Americas 5.1 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country 5.1.1 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country (2018-2023) 5.1.2 Americas Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Country (2018-2023) 5.2 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type 5.3 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Region 6.1.1 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Region (2018-2023) 6.1.2 APAC Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Region (2018-2023) 6.2 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type 6.3 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Wearable Non-invasive Blood Glucose Monitoring Device by Country 7.1.1 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country (2018-2023) 7.1.2 Europe Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Country (2018-2023) 7.2 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type 7.3 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device by Country 8.1.1 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country (2018-2023) 8.1.2 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Country (2018-2023) 8.2 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type 8.3 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Wearable Non-invasive Blood Glucose Monitoring Device 10.3 Manufacturing Process Analysis of Wearable Non-invasive Blood Glucose Monitoring Device 10.4 Industry Chain Structure of Wearable Non-invasive Blood Glucose Monitoring Device 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Wearable Non-invasive Blood Glucose Monitoring Device Distributors 11.3 Wearable Non-invasive Blood Glucose Monitoring Device Customer 12 World Forecast Review for Wearable Non-invasive Blood Glucose Monitoring Device by Geographic Region 12.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Market Size Forecast by Region 12.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Forecast by Region (2024-2029) 12.1.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Wearable Non-invasive Blood Glucose Monitoring Device Forecast by Type 12.7 Global Wearable Non-invasive Blood Glucose Monitoring Device Forecast by Application 13 Key Players Analysis 13.1 Know Labs 13.1.1 Know Labs Company Information 13.1.2 Know Labs Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.1.3 Know Labs Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Know Labs Main Business Overview 13.1.5 Know Labs Latest Developments 13.2 GraphWear 13.2.1 GraphWear Company Information 13.2.2 GraphWear Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.2.3 GraphWear Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 GraphWear Main Business Overview 13.2.5 GraphWear Latest Developments 13.3 ADI 13.3.1 ADI Company Information 13.3.2 ADI Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.3.3 ADI Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 ADI Main Business Overview 13.3.5 ADI Latest Developments 13.4 Quantum Operation 13.4.1 Quantum Operation Company Information 13.4.2 Quantum Operation Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.4.3 Quantum Operation Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Quantum Operation Main Business Overview 13.4.5 Quantum Operation Latest Developments 13.5 DiaMonTech 13.5.1 DiaMonTech Company Information 13.5.2 DiaMonTech Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.5.3 DiaMonTech Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 DiaMonTech Main Business Overview 13.5.5 DiaMonTech Latest Developments 13.6 Hagar Tech 13.6.1 Hagar Tech Company Information 13.6.2 Hagar Tech Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.6.3 Hagar Tech Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Hagar Tech Main Business Overview 13.6.5 Hagar Tech Latest Developments 13.7 LifePlus 13.7.1 LifePlus Company Information 13.7.2 LifePlus Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.7.3 LifePlus Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 LifePlus Main Business Overview 13.7.5 LifePlus Latest Developments 13.8 Afon Technology 13.8.1 Afon Technology Company Information 13.8.2 Afon Technology Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.8.3 Afon Technology Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Afon Technology Main Business Overview 13.8.5 Afon Technology Latest Developments 13.9 Abbott 13.9.1 Abbott Company Information 13.9.2 Abbott Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.9.3 Abbott Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Abbott Main Business Overview 13.9.5 Abbott Latest Developments 13.10 DexCom 13.10.1 DexCom Company Information 13.10.2 DexCom Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.10.3 DexCom Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 DexCom Main Business Overview 13.10.5 DexCom Latest Developments 13.11 Cnoga Medical 13.11.1 Cnoga Medical Company Information 13.11.2 Cnoga Medical Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.11.3 Cnoga Medical Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Cnoga Medical Main Business Overview 13.11.5 Cnoga Medical Latest Developments 13.12 Integrity Applications 13.12.1 Integrity Applications Company Information 13.12.2 Integrity Applications Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.12.3 Integrity Applications Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Integrity Applications Main Business Overview 13.12.5 Integrity Applications Latest Developments 13.13 Taiwan Biophotonic 13.13.1 Taiwan Biophotonic Company Information 13.13.2 Taiwan Biophotonic Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.13.3 Taiwan Biophotonic Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Taiwan Biophotonic Main Business Overview 13.13.5 Taiwan Biophotonic Latest Developments 13.14 MediWise 13.14.1 MediWise Company Information 13.14.2 MediWise Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.14.3 MediWise Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 MediWise Main Business Overview 13.14.5 MediWise Latest Developments 13.15 GlySens Incorporated 13.15.1 GlySens Incorporated Company Information 13.15.2 GlySens Incorporated Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.15.3 GlySens Incorporated Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 GlySens Incorporated Main Business Overview 13.15.5 GlySens Incorporated Latest Developments 13.16 GlucoWise 13.16.1 GlucoWise Company Information 13.16.2 GlucoWise Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.16.3 GlucoWise Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.16.4 GlucoWise Main Business Overview 13.16.5 GlucoWise Latest Developments 13.17 NXP 13.17.1 NXP Company Information 13.17.2 NXP Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.17.3 NXP Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.17.4 NXP Main Business Overview 13.17.5 NXP Latest Developments 13.18 Apple 13.18.1 Apple Company Information 13.18.2 Apple Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.18.3 Apple Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.18.4 Apple Main Business Overview 13.18.5 Apple Latest Developments 13.19 Huawei 13.19.1 Huawei Company Information 13.19.2 Huawei Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.19.3 Huawei Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.19.4 Huawei Main Business Overview 13.19.5 Huawei Latest Developments 14 Research Findings and Conclusion
SummaryAccording to our (LP Info Research) latest study, the global Wearable Non-invasive Blood Glucose Monitoring Device market size was valued at US$ million in 2022. With growing demand in downstream market and recovery from influence of COVID-19 and the Russia-Ukraine War, the Wearable Non-invasive Blood Glucose Monitoring Device is forecast to a readjusted size of US$ million by 2029 with a CAGR of % during review period. Table of Contents1 Scope of the Report1.1 Market Introduction 1.2 Years Considered 1.3 Research Objectives 1.4 Market Research Methodology 1.5 Research Process and Data Source 1.6 Economic Indicators 1.7 Currency Considered 1.8 Market Estimation Caveats 2 Executive Summary 2.1 World Market Overview 2.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales 2018-2029 2.1.2 World Current & Future Analysis for Wearable Non-invasive Blood Glucose Monitoring Device by Geographic Region, 2018, 2022 & 2029 2.1.3 World Current & Future Analysis for Wearable Non-invasive Blood Glucose Monitoring Device by Country/Region, 2018, 2022 & 2029 2.2 Wearable Non-invasive Blood Glucose Monitoring Device Segment by Type 2.2.1 Continuous 2.2.2 Intermittent 2.3 Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type 2.3.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Sales Market Share by Type (2018-2023) 2.3.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue and Market Share by Type (2018-2023) 2.3.3 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Price by Type (2018-2023) 2.4 Wearable Non-invasive Blood Glucose Monitoring Device Segment by Application 2.4.1 Sports & Entertainment 2.4.2 Medical 2.4.3 Medical Research 2.4.4 Others 2.5 Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application 2.5.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Market Share by Application (2018-2023) 2.5.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue and Market Share by Application (2018-2023) 2.5.3 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Price by Application (2018-2023) 3 Global Wearable Non-invasive Blood Glucose Monitoring Device by Company 3.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Breakdown Data by Company 3.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales by Company (2018-2023) 3.1.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Sales Market Share by Company (2018-2023) 3.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue by Company (2018-2023) 3.2.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Company (2018-2023) 3.2.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Revenue Market Share by Company (2018-2023) 3.3 Global Wearable Non-invasive Blood Glucose Monitoring Device Sale Price by Company 3.4 Key Manufacturers Wearable Non-invasive Blood Glucose Monitoring Device Producing Area Distribution, Sales Area, Product Type 3.4.1 Key Manufacturers Wearable Non-invasive Blood Glucose Monitoring Device Product Location Distribution 3.4.2 Players Wearable Non-invasive Blood Glucose Monitoring Device Products Offered 3.5 Market Concentration Rate Analysis 3.5.1 Competition Landscape Analysis 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023) 3.6 New Products and Potential Entrants 3.7 Mergers & Acquisitions, Expansion 4 World Historic Review for Wearable Non-invasive Blood Glucose Monitoring Device by Geographic Region 4.1 World Historic Wearable Non-invasive Blood Glucose Monitoring Device Market Size by Geographic Region (2018-2023) 4.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales by Geographic Region (2018-2023) 4.1.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue by Geographic Region (2018-2023) 4.2 World Historic Wearable Non-invasive Blood Glucose Monitoring Device Market Size by Country/Region (2018-2023) 4.2.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Sales by Country/Region (2018-2023) 4.2.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue by Country/Region (2018-2023) 4.3 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth 4.4 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth 4.5 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth 4.6 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales Growth 5 Americas 5.1 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country 5.1.1 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country (2018-2023) 5.1.2 Americas Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Country (2018-2023) 5.2 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type 5.3 Americas Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application 5.4 United States 5.5 Canada 5.6 Mexico 5.7 Brazil 6 APAC 6.1 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Region 6.1.1 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Region (2018-2023) 6.1.2 APAC Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Region (2018-2023) 6.2 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type 6.3 APAC Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application 6.4 China 6.5 Japan 6.6 South Korea 6.7 Southeast Asia 6.8 India 6.9 Australia 6.10 China Taiwan 7 Europe 7.1 Europe Wearable Non-invasive Blood Glucose Monitoring Device by Country 7.1.1 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country (2018-2023) 7.1.2 Europe Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Country (2018-2023) 7.2 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type 7.3 Europe Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application 7.4 Germany 7.5 France 7.6 UK 7.7 Italy 7.8 Russia 8 Middle East & Africa 8.1 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device by Country 8.1.1 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales by Country (2018-2023) 8.1.2 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Revenue by Country (2018-2023) 8.2 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales by Type 8.3 Middle East & Africa Wearable Non-invasive Blood Glucose Monitoring Device Sales by Application 8.4 Egypt 8.5 South Africa 8.6 Israel 8.7 Turkey 8.8 GCC Countries 9 Market Drivers, Challenges and Trends 9.1 Market Drivers & Growth Opportunities 9.2 Market Challenges & Risks 9.3 Industry Trends 10 Manufacturing Cost Structure Analysis 10.1 Raw Material and Suppliers 10.2 Manufacturing Cost Structure Analysis of Wearable Non-invasive Blood Glucose Monitoring Device 10.3 Manufacturing Process Analysis of Wearable Non-invasive Blood Glucose Monitoring Device 10.4 Industry Chain Structure of Wearable Non-invasive Blood Glucose Monitoring Device 11 Marketing, Distributors and Customer 11.1 Sales Channel 11.1.1 Direct Channels 11.1.2 Indirect Channels 11.2 Wearable Non-invasive Blood Glucose Monitoring Device Distributors 11.3 Wearable Non-invasive Blood Glucose Monitoring Device Customer 12 World Forecast Review for Wearable Non-invasive Blood Glucose Monitoring Device by Geographic Region 12.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Market Size Forecast by Region 12.1.1 Global Wearable Non-invasive Blood Glucose Monitoring Device Forecast by Region (2024-2029) 12.1.2 Global Wearable Non-invasive Blood Glucose Monitoring Device Annual Revenue Forecast by Region (2024-2029) 12.2 Americas Forecast by Country 12.3 APAC Forecast by Region 12.4 Europe Forecast by Country 12.5 Middle East & Africa Forecast by Country 12.6 Global Wearable Non-invasive Blood Glucose Monitoring Device Forecast by Type 12.7 Global Wearable Non-invasive Blood Glucose Monitoring Device Forecast by Application 13 Key Players Analysis 13.1 Know Labs 13.1.1 Know Labs Company Information 13.1.2 Know Labs Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.1.3 Know Labs Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.1.4 Know Labs Main Business Overview 13.1.5 Know Labs Latest Developments 13.2 GraphWear 13.2.1 GraphWear Company Information 13.2.2 GraphWear Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.2.3 GraphWear Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.2.4 GraphWear Main Business Overview 13.2.5 GraphWear Latest Developments 13.3 ADI 13.3.1 ADI Company Information 13.3.2 ADI Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.3.3 ADI Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.3.4 ADI Main Business Overview 13.3.5 ADI Latest Developments 13.4 Quantum Operation 13.4.1 Quantum Operation Company Information 13.4.2 Quantum Operation Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.4.3 Quantum Operation Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.4.4 Quantum Operation Main Business Overview 13.4.5 Quantum Operation Latest Developments 13.5 DiaMonTech 13.5.1 DiaMonTech Company Information 13.5.2 DiaMonTech Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.5.3 DiaMonTech Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.5.4 DiaMonTech Main Business Overview 13.5.5 DiaMonTech Latest Developments 13.6 Hagar Tech 13.6.1 Hagar Tech Company Information 13.6.2 Hagar Tech Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.6.3 Hagar Tech Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.6.4 Hagar Tech Main Business Overview 13.6.5 Hagar Tech Latest Developments 13.7 LifePlus 13.7.1 LifePlus Company Information 13.7.2 LifePlus Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.7.3 LifePlus Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.7.4 LifePlus Main Business Overview 13.7.5 LifePlus Latest Developments 13.8 Afon Technology 13.8.1 Afon Technology Company Information 13.8.2 Afon Technology Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.8.3 Afon Technology Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.8.4 Afon Technology Main Business Overview 13.8.5 Afon Technology Latest Developments 13.9 Abbott 13.9.1 Abbott Company Information 13.9.2 Abbott Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.9.3 Abbott Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.9.4 Abbott Main Business Overview 13.9.5 Abbott Latest Developments 13.10 DexCom 13.10.1 DexCom Company Information 13.10.2 DexCom Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.10.3 DexCom Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.10.4 DexCom Main Business Overview 13.10.5 DexCom Latest Developments 13.11 Cnoga Medical 13.11.1 Cnoga Medical Company Information 13.11.2 Cnoga Medical Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.11.3 Cnoga Medical Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.11.4 Cnoga Medical Main Business Overview 13.11.5 Cnoga Medical Latest Developments 13.12 Integrity Applications 13.12.1 Integrity Applications Company Information 13.12.2 Integrity Applications Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.12.3 Integrity Applications Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.12.4 Integrity Applications Main Business Overview 13.12.5 Integrity Applications Latest Developments 13.13 Taiwan Biophotonic 13.13.1 Taiwan Biophotonic Company Information 13.13.2 Taiwan Biophotonic Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.13.3 Taiwan Biophotonic Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.13.4 Taiwan Biophotonic Main Business Overview 13.13.5 Taiwan Biophotonic Latest Developments 13.14 MediWise 13.14.1 MediWise Company Information 13.14.2 MediWise Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.14.3 MediWise Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.14.4 MediWise Main Business Overview 13.14.5 MediWise Latest Developments 13.15 GlySens Incorporated 13.15.1 GlySens Incorporated Company Information 13.15.2 GlySens Incorporated Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.15.3 GlySens Incorporated Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.15.4 GlySens Incorporated Main Business Overview 13.15.5 GlySens Incorporated Latest Developments 13.16 GlucoWise 13.16.1 GlucoWise Company Information 13.16.2 GlucoWise Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.16.3 GlucoWise Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.16.4 GlucoWise Main Business Overview 13.16.5 GlucoWise Latest Developments 13.17 NXP 13.17.1 NXP Company Information 13.17.2 NXP Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.17.3 NXP Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.17.4 NXP Main Business Overview 13.17.5 NXP Latest Developments 13.18 Apple 13.18.1 Apple Company Information 13.18.2 Apple Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.18.3 Apple Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.18.4 Apple Main Business Overview 13.18.5 Apple Latest Developments 13.19 Huawei 13.19.1 Huawei Company Information 13.19.2 Huawei Wearable Non-invasive Blood Glucose Monitoring Device Product Portfolios and Specifications 13.19.3 Huawei Wearable Non-invasive Blood Glucose Monitoring Device Sales, Revenue, Price and Gross Margin (2018-2023) 13.19.4 Huawei Main Business Overview 13.19.5 Huawei Latest Developments 14 Research Findings and Conclusion
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(医療)の最新刊レポート
LP Information社の医療分野での最新刊レポート本レポートと同じKEY WORD(device)の最新刊レポートよくあるご質問LP Information社はどのような調査会社ですか?LP Informationは通信、エネルギー、医薬をはじめとする広範な市場の調査とレポート出版を行っている調査会社です。 もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/15 10:26 157.84 円 166.62 円 202.61 円 |